Literature DB >> 6214757

Immunological aspects of Giardia muris and Spironucleus muris infections in inbred and outbred strains of laboratory mice: a comparative study.

S J Brett, F E Cox.   

Abstract

The intestinal flagellates, Giardia muris and Spironucleus muris, cause similar infections in CBA mice as determined by trophozoite and cyst counts. Both parasites occur all along the small intestine with G. muris, being mainly present in the anterior part and S. muris towards the posterior. The early stages of infection are similar in all strains of mice examined and peak levels of both trophozoites and cysts occur 1-2 weeks after infection. All strains of mice overcome the infection but the rate of recovery varies considerably between strains, being most rapid in BALB/c and slowest in A and C57BL.B10. Outbred mice are more variable in their recovery than inbred mice. After recovery, mice are partially resistant to reinfection with the homologous but not the heterologous parasite. Resistance to reinfection with S. muris is greatest in those strains that eliminate the primary infection most rapidly. Giardia muris and S. muris cause similar changes in the mucosa of the small intestine of BALB/c mice with increased intra-epithelial lymphocyte counts from 3 weeks onwards corresponding with the start of the elimination of the parasites from the gut. A reduction in villus height and increase in crypt depth is also characteristic of these infections.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6214757     DOI: 10.1017/s0031182000054172

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  13 in total

1.  Efficacy of direct detection of pathogens in naturally infected mice by using a high-density PCR array.

Authors:  Kenneth S Henderson; Cheryl L Perkins; Richard B Havens; Mee-Jin E Kelly; Brian C Francis; Vandana S Dole; William R Shek
Journal:  J Am Assoc Lab Anim Sci       Date:  2013-11       Impact factor: 1.232

Review 2.  Immune response to Giardia duodenalis.

Authors:  G Faubert
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

3.  Chronic giardiasis in B-cell-deficient mice expressing the xid gene.

Authors:  D P Snider; D Skea; B J Underdown
Journal:  Infect Immun       Date:  1988-11       Impact factor: 3.441

4.  Antibody response to Giardia muris trophozoites in mouse intestine.

Authors:  M F Heyworth
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.441

5.  Detection of Spironucleus muris in unpreserved mouse tissue and fecal samples by using a PCR assay.

Authors:  Michelle A Fain; Zuzana Karjala; Kathy A Perdue; Michelle K Copeland; Lily I Cheng; William R Elkins
Journal:  J Am Assoc Lab Anim Sci       Date:  2008-09       Impact factor: 1.232

6.  Suboptimal ability of dirty-bedding sentinels to detect Spironucleus muris in a colony of mice with genetic manipulations of the adaptive immune system.

Authors:  Kathy A Perdue; Michelle K Copeland; Zuzana Karjala; Lily I Cheng; Jerrold M Ward; William R Elkins
Journal:  J Am Assoc Lab Anim Sci       Date:  2008-09       Impact factor: 1.232

7.  Quantitative and temporal analyses of murine antibody response in serum and gut secretions to infection with Giardia muris.

Authors:  D P Snider; B J Underdown
Journal:  Infect Immun       Date:  1986-04       Impact factor: 3.441

8.  Development of a PCR assay for the detection of Spironucleus muris.

Authors:  Glenn A Jackson; Robert S Livingston; Lela K Riley; Beth A Livingston; Craig L Franklin
Journal:  J Am Assoc Lab Anim Sci       Date:  2013-03       Impact factor: 1.232

9.  Harvesting of leukocytes from intestinal lumen in murine giardiasis and preliminary characterization of these cells.

Authors:  M F Heyworth; R L Owen; W E Seaman; F W Schaefer; A L Jones
Journal:  Dig Dis Sci       Date:  1985-02       Impact factor: 3.199

10.  Clearance of Giardia muris infection requires helper/inducer T lymphocytes.

Authors:  M F Heyworth; J R Carlson; T H Ermak
Journal:  J Exp Med       Date:  1987-06-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.